• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Adhezion Biomedical, Pfizer ink long-term supply deal

September 13, 2016 By Sarah Faulkner

Adhezion, PfizerAdhezion Biomedical announced today that it inked a long-term supply deal with Pfizer (NYSE:PFE) for exclusive U.S. distribution rights for Adhezion’s topical skin adhesives.

The Wyomissing, Pa.-based medical device company has a product family of 2-octyl cyanoacrylate adhesives designed to hold the edges of skin wounds together, for use after minimally invasive surgery and simple lacerations from trauma. They can also be used in combination with deep dermal sutures, according to Adhezion.

“It is my pleasure to announce that the Surgiseal product family of brands can now be purchased from Pfizer Inc., in the U.S. and its territories and possessions,” chairman & CEO Pete Molinaro said in prepared remarks. “Pfizer is one of the world’s premier biopharmaceutical companies, and this partnership offers strong support for our business.”

Pfizer has not released an official statement on the deal, as of this morning. Its stock closed at $34.65 apiece yesterday, up 1.61%.

Filed Under: Distribution, Drug-Device Combinations, Surgical, Wound Care Tagged With: Adhezion Biomedical, Pfizer Inc.

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS